The current clinical trial landscape for hidradenitis suppurativa: a narrative review

A Hunt, V Qian, H Olds, S Daveluy - Dermatology and Therapy, 2023 - Springer
Hidradenitis suppurativa (HS) is a skin disease resulting from chronic, recurrent
inflammation around hair follicles, characterized by proinflammatory cytokines such as IL-1 …

Clinical implementation of biologics and small molecules in the treatment of hidradenitis suppurativa

P Aarts, K Dudink, ARJV Vossen, KR van Straalen… - Drugs, 2021 - Springer
Hidradenitis suppurativa (HS) is a chronic, recurrent, auto-inflammatory skin disease
originating from the hair follicles. The typical inflammatory nodules, abscesses, and draining …

New and emerging targeted therapies for hidradenitis suppurativa

A Markota Čagalj, B Marinović… - International journal of …, 2022 - mdpi.com
Hidradenitis suppurativa (HS) is a chronic, recurrent, inflammatory skin disease deriving
from the hair follicles. The formation of inflammatory nodules, abscesses, fistulas, and sinus …

Biologics for hidradenitis suppurativa: evolution of the treatment paradigm

CA Maronese, C Moltrasio, G Genovese… - Expert Review of …, 2024 - Taylor & Francis
Introduction Hidradenitis suppurativa (HS) is an autoinflammatory skin disease with a high
unmet need for effective medical management. Clinically, it is characterized by inflammatory …

Targeted treatments for hidradenitis suppurativa: a review of the current literature and ongoing clinical trials

M Maarouf, AK Clark, DE Lee, VY Shi - Journal of Dermatological …, 2018 - Taylor & Francis
Purpose: Targeted, immune-modulating drugs are at the forefront of therapy for HS, and a
comprehensive clinical trial registry is needed to facilitate data pooling and clinical efficacy …

[HTML][HTML] Narrative Review and Update on Biologic and Small Molecule Drugs for Hidradenitis Suppurativa: An Entity With a Promising Future

M Mansilla-Polo, B Escutia-Muñoz… - Actas dermo …, 2023 - Elsevier
Hidradenitis suppurativa (HS) is a chronic inflammatory entity characterized by the
appearance of multiple nodules, abscesses, and fistulas, predominantly in apocrine regions …

Hidradenitis Suppurativa: new targets and emerging treatments

JL Gao, TS Otto, ML Porter, AB Kimball - American Journal of Clinical …, 2024 - Springer
Hidradenitis suppurativa (HS) is a chronic inflammatory skin condition that can be
challenging to treat. Biologics and targeted small molecules have become an increasingly …

A Review of the Current Landscape of Hidradenitis Suppurativa Treatment Development.

L Westerkam, C Sayed - Journal of Drugs in Dermatology: JDD, 2023 - europepmc.org
Background Hidradenitis suppurativa (HS) is a chronic inflammatory skin condition
characterized by recurrent nodules and abscesses leading to subsequent scarring and …

Medical management of hidradenitis suppurativa with non-biologic therapy: what's new?

S Ghanian, M Yamanaka-Takaichi, HB Naik… - American journal of …, 2022 - Springer
Hidradenitis suppurativa (HS) is a severe chronic relapsing inflammatory disorder of the hair
follicle unit that can cause painful abscesses, nodules, tunnels, and tracts in intertriginous …

Pharmacological development in hidradenitis suppurativa

Ł Matusiak, GBE Jemec, JC Szepietowski - Current opinion in …, 2019 - Elsevier
Hidradenitis suppurativa (HS) is a chronic, inflammatory, debilitating disease of a relapsing
nature which presents with nodules, abscesses, and suppurating lesions of intertriginous …